Skip to main content
. 2022 Jul 27;276(5):860–867. doi: 10.1097/SLA.0000000000005634

TABLE 2.

Outcomes after Redo Liver Transplantation in 2 Higher-Risk Groups Compared With Benchmark Cutoffs

MELD ≥30 (n=112) Redo-LT for PNF (n=143) Redo-LT Benchmark Cutoff
Perioperative course
 Recipient hepatectomy duration, h 2.8 (2.0–4.2) 1.3 (0.6–2.2) ≤4.0
 Operation duration, h 7.8 (6.6–9.0) 5.0 (3.9–6.1) ≤8.1
 Blood transfusion, units of RBC 7 (4–17) 3 (0–6) ≤8
 Newly need for dialysis 35 (31) 31 (22) ≤20%
 Intensive care unit stay, d 6 (3–10) 14 (6–26) ≤6
 Hospital stay, d 20 (12–38) 27 (16–46) ≤21
Postoperative morbidity and mortality at 1 y
 Any complication 103 (92) 141 (99) ≤100%
 ≥Grade 3a complication 92 (82) 130 (91) ≤72%
 CCI® 60 (40–96) 86 (58–100) ≤72
 Primary nonfunction 4 (3.6) 18 (12.6) ≤2.7%
 Intra-abdominal Bleeding 31 (28) 26 (18) ≤23%
 Any biliary complication 22 (20) 21 (15) ≤30%
 Anastomotic stricture 15 (13) 12 (8.4) ≤25%
 Nonanastomotic stricture 3 (2.7) 0 (0) ≤5%
 Biliary leakage 9 (8.0) 9 (6.3) ≤9%
 Hepatic artery thrombosis 5 (4.5) 5 (3.5) ≤6.5%
 Graft-loss 29 (26) 58 (41) ≤20%
 Redo redo liver transplantation 8 (7) 3 (2) ≤11%
 Mortality 23 (21) 58 (41) ≤15%

Data shown as median and IQR or number and proportion (%).

RBC indicates red blood cells.